Catherine Pearce Builds Biotech Companies From the Assets Everyone Else Forgot

Her career began with a Roche sales bag and came full circle in a $1.8 billion biotech exit. Now the Cincinnati operator is running the play again, with a sharper eye for overlooked science and a bigger table for the people building it.